ALPS Medical Breakthroughs ETF
SBIO
SBIO
52 hedge funds and large institutions have $29.4M invested in ALPS Medical Breakthroughs ETF in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 15
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
52
Holding in Top 10
–
Calls
$498K
Puts
–
Top Buyers
| 1 | +$1.35M | |
| 2 | +$352K | |
| 3 | +$213K | |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
+$157K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$123K |
Top Sellers
| 1 | -$3.6M | |
| 2 | -$1.22M | |
| 3 | -$1.08M | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$986K |
| 5 |
Morgan Stanley
New York
|
-$582K |